(1-哌啶基甲基)三氟硼酸钾 | 888711-54-4

• 物质功能分类: 有机原料 - 有机氟化合物 - 氟硼酸钾系列
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: (1-哌啶基甲基)三氟硼酸钾
• 中文别名: 钾1-三氟硼酸甲基哌啶
• 英文名称: potassium 1-(trifluoroboratomethyl)piperidine
• 英文别名: Potassium (piperidin-1-YL)methyltrifluoroborate；potassium;trifluoro(piperidin-1-ylmethyl)boranuide
• CAS: 888711-54-4
• 化学式: C₆H₁₂BF₃N*K
• 分子量: 205.072
• InChiKey: WFAVOZJLYZWLRI-UHFFFAOYSA-N

物化性质

• 熔点：
  146-148℃

计算性质

• 辛醇/水分配系数(LogP)：
  -1.14
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 海关编码：
  29319090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Potassium (piperidin-1-yl)methyltrifluoroborate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Potassium (piperidin-1-yl)methyltrifluoroborate
CAS number: 888711-54-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H12BF3N.K
Molecular weight: 205.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (1-哌啶基甲基)三氟硼酸钾 在 盐酸 、 bis-triphenylphosphine-palladium(II) chloride 、 盐酸羟胺 、 palladium diacetate 、 caesium carbonate 、 一水合肼 、 2-二环己基磷-2,4,6-三异丙基联苯 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 甲醇 、 水 、 正丁醇 为溶剂， 反应 29.5h， 生成 (E)-1-(3-((3-(piperidin-1-ylmethyl)quinolin-6-yl)methyl)[1,2,4]triazolo[4,3-b]pyridazin-6-yl)ethanone oxime
  参考文献：
  名称：

  [1,2,4] TRIAZOLO [4,3-B] PYRIDAZINE COMPOUNDS AS INHIBITORS OF THE C-MET TYROSINE KINASE

  摘要：

  该发明涉及公式（I）的化合物及其盐：其中取代基如规范中定义；公式（I）的化合物用于治疗人体或动物体，特别是涉及c-Met酪氨酸激酶介导的疾病或病况；公式（I）的化合物用于制造用于治疗此类疾病的药物；包含公式（I）的化合物的药物组合物，可选地与联合伙伴一起，并且公式（I）的化合物的制备方法。

  公开号：

  US20130324526A1
• 作为产物：
  描述：

  (吡啶鎓-1-基甲基)三氟硼酸盐 在 potassium hydrogencarbonate 作用下， 以 丙酮 为溶剂， 生成 (1-哌啶基甲基)三氟硼酸钾
  参考文献：
  名称：

  Reinvestigation of Aminomethyltrifluoroborates and Their Application in Suzuki−Miyaura Cross-Coupling Reactions

  摘要：

  A reinvestigation into the chemical composition of potassium aminomethyltrifluoroborates is reported. These trifluoroborato salts have been reassigned as zwitterionic ammoniomethyltrifluoroborates. Minor adjustments to the previously disclosed reaction conditions are reported that permit a similar level of activity as nucleophiles in Suzuki-Miyaura cross-coupling reactions.

  DOI：

  10.1021/jo2001066

文献信息

• Aminomethylation via Cyclopalladated-Ferrocenylimine-Complexes-Catalyzed Suzuki-Miyaura Coupling of Aryl Halides with Potassium N,N-Dialkylaminomethyltrifluoroborates
  作者：Yangjie Wu、Yusheng Wu、Dapeng Zou、Hongmeng Cui、Lijin Qin、Jingya Li

  DOI：10.1055/s-0030-1259331

  日期：2011.2

  Using cyclopalladated ferrocenylimine complexes (1-3 mol%) as catalysts, the Suzuki-Miyaura coupling of potassium N,N-dialkylaminomethyltrifluoroborates with aryl and heteroaryl halides were carried out in a 10:1 THF-H2O mixture at 80 ˚C in the presence of Cs2CO3 (3.0 equiv) as base, giving the desired cross-coupling products in 14-87% yields. A variety of potassium alkyltrifluoroborates were also examined.

  使用环钯化二茂铁亚胺配合物（1-3摩尔%）作为催化剂，在Cs2CO3（3.0当量）作为碱的存在下，在80 ℃的10:1 THF-H2O混合物中，进行钾N,N-二烷基氨基甲基三氟硼酸盐与芳基和杂芳基卤化物的铃木-宫浦偶联反应，得到了所需的交叉偶联产物，产率为14-87%。还研究了各种烷基三氟硼酸钾。
• Cu(II)-Catalyzed <i>ortho</i>-Selective Aminomethylation of Phenols
  作者：Jin-Ling Dai、Nan-Qi Shao、Jin Zhang、Run-Ping Jia、Dong-Hui Wang

  DOI：10.1021/jacs.7b06785

  日期：2017.9.13

  A Cu(II)-catalyzed ortho-selective functionalization of free phenols with trifluoroborates to afford Csp2-Csp3 coupling products under mild conditions has been developed. A variety of functional groups on the phenol and the potassium aminomethyltrifluoroborate substrates were found compatible, furnishing the corresponding products in moderate to excellent yields. A single-electron transfer radical

  已经开发出一种 Cu(II) 催化的游离酚与三氟硼酸盐的邻位选择性官能化，以在温和条件下提供 Csp2-Csp3 偶联产物。发现苯酚和氨基甲基三氟硼酸钾底物上的各种官能团是相容的，以中等至极好的收率提供相应的产品。提出了一种涉及六元过渡态的单电子转移自由基偶联机制，以合理化反应中的高水平邻位选择性。该协议提供了对邻氨基甲基取代酚、非天然氨基酸和其他生物活性小分子的直接访问。
• [EN] 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS<br/>[FR] ANALOGUES DE PYRIDAZINE 1,4-DISUBSTITUÉE ET PROCÉDÉS DE TRAITEMENT DE TROUBLES LIÉS À UNE DÉFICIENCE EN SMN
  申请人：NOVARTIS AG

  公开号：WO2014028459A1

  公开（公告）日：2014-02-20

  The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明提供了一种公式(I)的化合物或其药用可接受的盐；一种制造本发明化合物的方法及其治疗用途。本发明进一步提供了一种药物活性剂的组合物和一种药物组合物。
• [EN] PROTEIN KINASE INHIBITORS AND METHODS OF TREATMENT<br/>[FR] INHIBITEUR DE PROTÉINE KINASES ET MÉTHODES DE TRAITEMENT
  申请人：INST MEDICAL W & E HALL

  公开号：WO2012003544A1

  公开（公告）日：2012-01-12

  The present invention relates to chemical compounds of formula (I) and methods for their use and preparation. In particular, the invention relates to substituted pyrazolo[3,4-d]pyrimidine based compounds which can be used in treating proliferative disorders, use of these compounds in methods of therapy and the manufacture of medicaments as well as compositions containing these compounds.

  本发明涉及化合物的化学式(I)以及其使用和制备方法。具体而言，本发明涉及基于取代的吡唑并[3,4-d]嘧啶的化合物，可用于治疗增殖性疾病，这些化合物在治疗方法中的使用以及药物的制造，以及含有这些化合物的组合物。
• Triazole-Based Inhibitors of the Wnt/β-Catenin Signaling Pathway Improve Glucose and Lipid Metabolisms in Diet-Induced Obese Mice
  作者：Obinna N. Obianom、Yong Ai、Yingjun Li、Wei Yang、Dong Guo、Hong Yang、Srilatha Sakamuru、Menghang Xia、Fengtian Xue、Yan Shu

  DOI：10.1021/acs.jmedchem.8b01408

  日期：2019.1.24

  implicated in the etiology and progression of metabolic disorders. Although lines of genetic evidence suggest that blockage of this pathway yields favorable outcomes in treating such ailments, few inhibitors have been used to validate the promising genetic findings. Here, we synthesized and characterized a novel class of triazole-based Wnt/β-catenin signaling inhibitors and assessed their effects on energy

  Wnt /β-catenin信号传导途径与代谢紊乱的病因和进展有关。尽管遗传证据表明该途径的阻断在治疗此类疾病方面产生了有利的结果，但很少有抑制剂被用于验证有前途的遗传发现。在这里，我们合成和表征了一类新型的基于三唑的Wnt /β-catenin信号抑制剂，并评估了它们对能量代谢的影响。最重要的抑制剂之一化合物3a促进了Axin的稳定，从而导致蛋白酶体降解β-catenin，并随后抑制了细胞中Wnt /β-catenin的信号传导。用化合物3a处理肝细胞和高脂饮食喂养的小鼠导致肝脂质蓄积明显减少。而且，化合物3a改善了高脂饮食喂养小鼠的葡萄糖耐量，而没有明显的毒性，同时下调了参与葡萄糖和脂肪酸代谢的基因。预期将进一步开发新的抑制剂来治疗代谢紊乱。